Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$4.80
NASDAQLPCN
Open
$4.52
Change
$0.25 (5.44%)
Day's Range
$4.51 - $4.81
52-Week Range
$2.31 - $7.15
Volume
19.8K
Market Cap
$25.5M
Currency in USD.
Quote data delayed by at least 15 minutes.